Case Study: Lyell Immunopharma achieves centralized R&D, improved data quality, and 3× faster analysis with Benchling

Lyell Immunopharma - Customer Case Study

Lyell Immunopharma is a clinical‑stage T‑cell reprogramming company in South San Francisco developing cell therapies to overcome barriers to treating solid tumors. From day one Lyell needed a cloud‑native, extensible, paperless system of record to support reproducible R&D and in‑life studies, manage candidate product identity and sequence integrity, and eliminate data silos and manual copying across teams.

Lyell implemented Benchling (ELN, Benchling Studies, APIs and data‑warehouse integration) to centralize experimental records, standardize templates and automate in‑life study workflows. The result: fewer data errors, automated dashboards and reports that accelerate insight generation, three‑times faster search/collation/analysis for R&D (including NGS), improved sample utilization and traceability that supports IND filings and overall faster, more reliable research.

Lyell Immunopharma

Anna Spektor

Director, Data Analytics, Research